Home
Eric Benevich, Chief Commercial Officer: Neurocrine Biosciences NBIX Sell · Filed 25/02/04
Trade details
- Type
- Insider sale
- Amount
- $184,598.58
- Shares · price
- 1,207 sh · $152.94 a share
- Held after
- 41,919 sh
- Trade date
- 25/01/31
- Filed
- 25/02/04
- Days to filing
- 4 days
Sold 2.8% of holdings
- Share of holding sold
- 2.8%
Neurocrine Biosciences trades, last 26 weeks
What else happened in Neurocrine Biosciences around then
Filed or reported within 30 days of the trade day · 25/01/01~25/03/02Eric Benevich's recent trades
- Eric Benevich
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 planNeurocrine Biosciences
NBIX
$334.2K
2,154 sh
$334.2K
Filed 09/09
Traded 09/09
- Eric Benevich
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$905.9K
5,970 sh
$905.9K
Filed 25/12/02
Traded 25/11/28
- Eric Benevich
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 planNeurocrine Biosciences
NBIX
$904.9K
5,970 sh
$904.9K
Filed 25/11/28
Traded 25/11/28
- Eric Benevich
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$128.2K
1,098 sh
$128.2K
Filed 25/02/14
Traded 25/02/13
- Eric Benevich
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$123.2K
1,056 sh
$123.2K
Filed 25/02/14
Traded 25/02/13